CholesteRITE
CholesteRITE, licence 80142409: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Canpower health inc.
- NPN or DIN-HM
- 80142409
- Status
- Active licence
- Licence date
- 4 July 2025
- Revision date
- 17 February 2026
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 50.0 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 76.0 mg Docosahexaenoic acid | 380.0 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 76.0 mg Docosahexaenoic acid | 380.0 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 152.0 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 152.0 mg Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Poudre de caroube, Mélange de concentré de tocophérol, Cire d'abeille jaune, Lécithine, Gélatine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support/maintain (normal) heart/cardiovascular function. Helps support/maintain (normal) heart/cardiovascular health. Helps support/maintain brain function. Helps support/maintain cognitive health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Helps lower bad cholesterol. Helps lower blood total and low density lipoprotein (LDL) cholesterol. Helps maintain healthy cholesterol levels. (Provides) An antioxidant. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80142409
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.